QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
NASDAQ:PPH

VanEck Vectors Pharmaceutical ETF News Headlines

$74.61
+0.88 (+1.19%)
(As of 01/27/2022 04:00 PM ET)
Add
Compare
Today's Range
$74.13
▼
$75.44
50-Day Range
$71.36
▼
$78.11
52-Week Range
$65.24
▼
$78.16
Volume
126,964 shs
Average Volume
76,626 shs
Market Capitalization
$383.35 million
P/E Ratio
N/A
Dividend Yield
1.70%
Beta
N/A
Get VanEck Vectors Pharmaceutical ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

VanEck Vectors Pharmaceutical ETF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PPH
News Sentiment
▼
0.50

0.26
▲
Average
Manufacturing
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PPH Articles
This Week
▼
1

0
▲
PPH Articles
Average Week



VanEck Vectors Pharmaceutical ETF (NASDAQ:PPH) News Headlines Today

SourceHeadline
thestreet.com logo3 Must-Watch Economic Indicators for the Summer
thestreet.com - January 13 at 8:00 PM
nasdaq.com logoPharma Could Be Place to Be for Healthcare Winners, Value
nasdaq.com - January 7 at 6:30 PM
nasdaq.com logoPharma Could Be Fabulous in 2022
nasdaq.com - December 20 at 3:57 PM
finance.yahoo.com logoVanEck Africa Index ETF Buys Helios Towers PLC, Capitec Bank Holdings, First Quantum Minerals, ...
finance.yahoo.com - December 14 at 10:51 PM
nasdaq.com logo3 Great Dividend ETFs to Get Paid With in 2022
nasdaq.com - December 9 at 12:44 PM
nasdaq.com logoWrite a Prescription for Pharma Dividends With PPH
nasdaq.com - December 9 at 12:44 PM
nasdaq.com logoThere’s Power Lurking in This Pharma ETF
nasdaq.com - November 15 at 2:00 PM
nasdaq.com logoPPH Pertinent as Some Cheap Pharma Stocks Offer Big Dividend Growth
nasdaq.com - November 10 at 8:29 AM
nasdaq.com logoPharma ETFs Gain on Q2 Earnings
nasdaq.com - August 6 at 12:43 PM
nasdaq.com logoAlzheimer’s Drug Cost Pushes Pharmaceutical Prices Back Into the Spotlight
nasdaq.com - August 5 at 3:10 PM
nasdaq.com logoArtificial Intelligence Set to Transform the Pharmaceutical Industry
nasdaq.com - June 1 at 5:30 PM
fool.com logoVanEck Vectors Pharmaceutical
fool.com - January 9 at 10:37 PM
barrons.com logoVanEck Vectors Pharmaceutical ETF
barrons.com - December 11 at 11:16 PM
seekingalpha.com logoVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.2493
seekingalpha.com - October 1 at 1:23 PM
seekingalpha.com logoGold: The Correction Is Over, Buying Opportunity Remains
seekingalpha.com - August 18 at 9:38 AM
seekingalpha.com logoVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.2523
seekingalpha.com - July 1 at 1:01 PM
finance.yahoo.com logoBest Performing Pharmaceutical ETFs for Q3 2020
finance.yahoo.com - May 13 at 12:48 PM
www.nasdaq.com logoTop-Ranked ETFs & Stocks to Buy From Bargain Industries
www.nasdaq.com - April 10 at 12:09 AM
www.nasdaq.com logoBiotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress
www.nasdaq.com - April 7 at 10:34 PM
finance.yahoo.com logoVanEck Vectors Pharmaceutical ETF (PPH)
finance.yahoo.com - July 24 at 3:35 PM
seekingalpha.com logoVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.2810
seekingalpha.com - July 1 at 3:28 PM
finance.yahoo.com logoLegal Troubles Beset Pharmaceutical Sector ETFs
finance.yahoo.com - May 17 at 8:48 AM
finance.yahoo.com logoA Look at Pharma ETFs Post Q4 Results
finance.yahoo.com - February 7 at 3:17 PM
finance.yahoo.com logoAnnouncing VanEck Vectors Equity ETFs December 2018 Distribution
finance.yahoo.com - December 27 at 11:11 AM
Get VanEck Vectors Pharmaceutical ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.